• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

FDA Drug Shortages

  • Print
  • Share
  • E-mail
-

Current and Resolved Drug Shortages and Discontinuations Reported to FDA

Start Over | Back to Previous Screen

 Nitroglycerin in 5% Dextrose Injection

 Status: Currently in Shortage

 » Date first reported: 12/20/2013
 » Therapeutic Categories: Cardiovascular

Baxter Healthcare (Reverified 10/15/2014)

Company Contact Information:
888-229-0001

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
25 mg Nitroglycerin in 5% Dextrose Injection; code 1A0692 (0338-1047-02) All presentations available. Demand increase for the drug
50 mg Nitroglycerin in 5% Dextrose Injection; code 1A0694 (0338-1049-02) All presentations available. Demand increase for the drug
100 mg Nitroglycerin in 5% Dextrose Injection; code 1A0696 (0338-1051-02) All presentations available. Demand increase for the drug

Hospira, Inc. (Reverified 10/23/2014)

Company Contact Information:
877-946-7747

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
200 mcg/mL; 250 mL bottle (NDC 0409-1482-02) Next delivery and recovery TBD Shortage per Manufacturer: Manufacturing delay. Other
100 mcg/mL; 250 mL bottle (NDC 0409-1483-02) Next delivery and recovery TBD Shortage per Manufacturer: Manufacturing delay. Other
100 mcg/mL; 500 mL bottle (NDC 0409-1483-03) Next delivery and recovery TBD Shortage per Manufacturer: Manufacturing delay. Other
400 mcg/mL; 250 mL bottle (NDC 0409-1484-02) Next delivery and recovery TBD Shortage per Manufacturer: Manufacturing delay. Other
-
-